In addition to genetic variability, several other internal and external factors play a role in medication metabolism.
Understanding social mechanisms that underlie these differences can help practitioners create tailored interventions for pain in these populations.
In terms of sustainability, medicine must address the foundational elements of a patient's symptoms to be effective and sustainable.
Off-label use of commercially available cosmetic cross-linked hyaluronic acid provided relief in patients with neuropathic pain.
Drug screening is increasingly becoming part of the standard of care in pain management.
Multiple neurotransmitters and proteins that are targeted in existing migraine therapies may also play a role in modulating satiety.
No increased risk for opioid withdrawal observed among patients on full mu-opioid agonist therapy who were switched to a buprenorphine buccal film without tapering.
Patients with chronic pain are already stigmatized, distrustful of physicians, and vulnerable to coercion.
Sometimes the prescription becomes the problem when patients become less sensitive to opioids.
Prescription drug monitoring programs offer prescribers another tool to prevent opioid abuse, misuse, and diversion.
Department of Defense and Veterans Health Administration Initiatives Support Comprehensive Pain Management ApproachesSeptember 18, 2015
The Joint Pain Education Program and the Acupuncture Training Across Clinical Settings are two initiatives currently underway to improve comprehensive pain management for veterans.
Creating better patient-centered, multidisciplinary pain management approaches will require cultural transformation.
Clinical Pain Advisor Articles
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Half of Patients Referred for Behavioral Treatment of Migraine Never Initiate Treatment
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness